Skip to main content
WallStreetDigest.

Search

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Atrium Therapeutics (RNA)

$8.05 −$0.15 (−1.83%)

Day’s range
$7.98–$8.23
Volume
187,367

RNA price history

RNA closed at $8.05 on Oct. 26, 2026. Over the past year, its daily close ranged from $7.61 on Oct. 19, 2026 to $16.54 on March 4, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $8 to $18, not from zero.
Data table: RNA daily closes, the past year
RNA daily closing prices, Feb. 27, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$8.05
Oct. 23, 2026$8.20
Oct. 22, 2026$8.16
Oct. 21, 2026$8.00
Oct. 20, 2026$7.98
Oct. 19, 2026$7.61
Oct. 16, 2026$7.67
Oct. 15, 2026$7.82
Oct. 14, 2026$7.68
Oct. 13, 2026$7.75
Oct. 12, 2026$8.21
Oct. 9, 2026$8.40
Oct. 8, 2026$8.26
Oct. 7, 2026$7.93
Oct. 6, 2026$7.99
Oct. 5, 2026$7.97
Oct. 2, 2026$7.84
Oct. 1, 2026$8.14
Sept. 30, 2026$8.28
Sept. 29, 2026$8.42
Sept. 28, 2026$8.42
Sept. 25, 2026$8.29
Sept. 24, 2026$8.19
Sept. 23, 2026$8.33
Sept. 22, 2026$9.22
Sept. 21, 2026$9.19
Sept. 18, 2026$8.95
Sept. 17, 2026$9.56
Sept. 16, 2026$9.50
Sept. 15, 2026$10.09
Sept. 14, 2026$10.21
Sept. 11, 2026$10.36
Sept. 10, 2026$10.35
Sept. 9, 2026$10.51
Sept. 8, 2026$11.35
Sept. 4, 2026$14.19
Sept. 3, 2026$14.60
Sept. 2, 2026$14.06
Sept. 1, 2026$13.77
Aug. 31, 2026$13.32
Aug. 28, 2026$13.64
Aug. 27, 2026$13.98
Aug. 26, 2026$13.85
Aug. 25, 2026$14.00
Aug. 24, 2026$13.62
Aug. 21, 2026$13.20
Aug. 20, 2026$13.48
Aug. 19, 2026$13.71
Aug. 18, 2026$12.84
Aug. 17, 2026$12.96
Aug. 14, 2026$12.84
Aug. 13, 2026$12.33
Aug. 12, 2026$12.17
Aug. 11, 2026$12.27
Aug. 10, 2026$12.24
Aug. 7, 2026$12.34
Aug. 6, 2026$12.11
Aug. 5, 2026$11.74
Aug. 4, 2026$11.54
Aug. 3, 2026$11.33
July 31, 2026$11.35
July 30, 2026$11.46
July 29, 2026$11.18
July 28, 2026$11.49
July 27, 2026$11.57
July 24, 2026$11.49
July 23, 2026$11.91
July 22, 2026$12.17
July 21, 2026$12.29
July 20, 2026$11.76
July 17, 2026$12.15
July 16, 2026$12.16
July 15, 2026$12.30
July 14, 2026$12.22
July 13, 2026$12.22
July 10, 2026$12.46
July 9, 2026$12.91
July 8, 2026$13.37
July 7, 2026$13.24
July 6, 2026$13.01
July 2, 2026$13.65
July 1, 2026$13.30
June 30, 2026$13.45
June 29, 2026$13.65
June 26, 2026$13.19
June 25, 2026$12.78
June 24, 2026$12.83
June 23, 2026$12.81
June 22, 2026$12.94
June 18, 2026$12.66
June 17, 2026$12.48
June 16, 2026$12.61
June 15, 2026$12.75
June 12, 2026$12.37
June 11, 2026$12.43
June 10, 2026$11.67
June 9, 2026$11.76
June 8, 2026$11.55
June 5, 2026$11.80
June 4, 2026$12.30
June 3, 2026$12.17
June 2, 2026$12.25
June 1, 2026$12.68
May 29, 2026$13.00
May 28, 2026$13.36
May 27, 2026$13.00
May 26, 2026$13.06
May 22, 2026$13.09
May 21, 2026$13.04
May 20, 2026$12.72
May 19, 2026$12.95
May 18, 2026$12.95
May 15, 2026$13.23
May 14, 2026$13.27
May 13, 2026$13.30
May 12, 2026$13.14
May 11, 2026$13.25
May 8, 2026$13.07
May 7, 2026$12.96
May 6, 2026$13.09
May 5, 2026$12.91
May 4, 2026$12.87
May 1, 2026$13.43
April 30, 2026$12.77
April 29, 2026$12.99
April 28, 2026$12.55
April 27, 2026$12.90
April 24, 2026$13.49
April 23, 2026$13.85
April 22, 2026$13.66
April 21, 2026$13.53
April 20, 2026$14.30
April 17, 2026$14.41
April 16, 2026$14.03
April 15, 2026$14.54
April 14, 2026$14.02
April 13, 2026$13.30
April 10, 2026$12.71
April 9, 2026$13.72
April 8, 2026$13.70
April 7, 2026$13.99
April 6, 2026$13.67
April 2, 2026$13.44
April 1, 2026$13.47
March 31, 2026$13.37
March 30, 2026$13.55
March 27, 2026$13.23
March 26, 2026$13.10
March 25, 2026$13.09
March 24, 2026$13.20
March 23, 2026$13.20
March 20, 2026$13.13
March 19, 2026$12.69
March 18, 2026$12.32
March 17, 2026$13.77
March 16, 2026$13.79
March 13, 2026$13.75
March 12, 2026$14.54
March 11, 2026$14.80
March 10, 2026$14.67
March 9, 2026$14.79
March 6, 2026$14.82
March 5, 2026$15.47
March 4, 2026$16.54
March 3, 2026$15.67
March 2, 2026$14.91
Feb. 27, 2026$14.75

Key figures

Average daily volume
270,581Past 3 months
Market value
$137.7M
Dividend yield
—

Price change

1 month
−2.90%
3 months
−29.94%

What Wall Street says about RNA

In the past 90 days, Wall Street firms published 3 rating or price-target actions on RNA: 2 new ratings and 1 reiterated rating.

Rating and price-target actions on RNA, past 90 days
ActionRating
Roth CapitalInitiates coverageBuy$15
HC Wainwright & Co.ReiteratesBuy$25
HC Wainwright & Co.Initiates coverageBuy$25

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Atrium Therapeutics, Inc. Common Stock

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Headquarters
San Diego, Calif.
Employees
391
Listed
Feb. 27, 2026
Sector
Health care
Industry
Pharmaceutical preparations

aviditybiosciences.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about RNA is on the site yet.

  • LLYEli Lilly & Co.
  • JNJJohnson & Johnson
  • ABBVABBVIE INC.
  • MRKMerck & Co., Inc.
  • ABTAbbott Laboratories
  • PFEPfizer Inc.